YTHDC1 and colorectal carcinoma: Another example is m6A-modified circFNDC3B, which, influenced by YTHDC1, can inhibit CRC progression and metastasis by binding to FXR2, maintaining RNF41 stabilization, and promoting the ubiquitination and degradation of ASB6 [114].